Physician profile
Conan Tu
NPI 1083794440
$319,787.60
in general payments reported to CMS, 2019-2025
64 companies · $198K in 2025
The $198K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,085 · 2020: $3,127 · 2021: $11K · 2022: $9,605 · 2023: $8,375 · 2024: $80K · 2025: $198K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $139K · Consulting Fee: $79K · Travel and Lodging: $35K · Food and Beverage: $26K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $139,065.50 |
| Consulting Fee | $79,297.00 |
| Travel and Lodging | $35,415.79 |
| Food and Beverage | $25,890.40 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $172,553.39 | 2019-2025 | |
| Sanofi US Services INC. | $25,403.06 | 2025 | |
| Novo Nordisk INC | $25,322.68 | 2019-2025 | Ozempic, Victoza, Wegovy |
| Genzyme Corporation | $22,775.58 | 2019-2025 | |
| Abbott Laboratories | $22,342.98 | 2019-2025 | Freestyle Libre 3, Mitraclip, Navitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,540.41 | 2019-2025 | Jardiance, Ofev, Synjardy |
| Astrazeneca Pharmaceuticals Lp | $9,100.32 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Insulet Corporation | $4,324.46 | 2021-2025 | Omnipod, Omnipod |
| Amgen INC. | $4,316.58 | 2019-2025 | Repatha, Evenity, Prolia |
| Lilly USA, LLC | $2,027.60 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Madrigal Pharmaceuticals | $2,023.95 | 2025 | Rezdiffra |
| Eli Lilly and Company | $1,950.00 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $1,823.31 | 2020-2021 | |
| Cvrx, INC. | $1,535.95 | 2022-2024 | Barostim Neo System |
| Boston Scientific Corporation | $1,513.19 | 2019-2025 | Watchman Flx, Watchman Access System |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,248.27 | 2019-2025 | Spravato |
| Amarin Pharma, INC. | $943.46 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $891.38 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $836.90 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Glaxosmithkline, LLC. | $833.86 | 2019-2025 | Trelegy Ellipta |
| Pfizer INC. | $796.56 | 2019-2025 | |
| Intuity Medical INC | $670.79 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Esperion Therapeutics, INC. | $668.94 | 2021-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $608.39 | 2019-2025 | Verquvo, Gardasil 9, Capvaxive |
| Axsome Therapeutics, INC. | $504.30 | 2023-2025 | Auvelity, Symbravo |
| Beta Bionics, INC. | $494.67 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Teva Pharmaceuticals USA, INC. | $429.82 | 2020-2022 | |
| Corcept Therapeutics | $411.60 | 2023-2025 | Korlym |
| Medtronic, INC. | $355.21 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $329.90 | 2021-2025 | |
| Eisai INC. | $325.35 | 2025 | |
| Novartis Pharmaceuticals Corporation | $295.16 | 2019-2025 | |
| Mannkind Corporation | $212.18 | 2022-2024 | |
| Dexcom, INC. | $194.19 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Abbvie INC. | $193.39 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $156.90 | 2022-2025 | Amvuttra |
| Heartflow, INC. | $140.42 | 2024 | |
| Amneal Pharmaceuticals LLC | $139.23 | 2024-2025 | Unithroid |
| Tandem Diabetes Care, INC. | $135.65 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ipsen Biopharmaceuticals, INC | $125.00 | 2024 | |
| Novo Nordisk As | $124.67 | 2023 | |
| Phathom Pharmaceuticals, INC. | $122.19 | 2024 | Voquezna |
| Alkermes, INC. | $113.59 | 2023 | Lybalvi |
| Djo, LLC | $103.73 | 2024 | Cmf |
| Daiichi Sankyo INC. | $102.61 | 2021 | |
| Recordati_rare_diseases_inc. | $97.44 | 2025 | Isturisa |
| Allergan, INC. | $84.03 | 2019-2020 | |
| Exact Sciences Corporation | $79.64 | 2023-2025 | Cologuard Collection Kit |
| Ascendis Pharma Endocrinology INC | $68.35 | 2025 | Yorvipath |
| Ibsa Pharma INC. | $49.16 | 2022 | |
| Renalytix Ai, INC. | $45.28 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Amryt Pharma Holdings Ltd | $39.38 | 2022 | |
| Sanofi Pasteur INC. | $37.80 | 2019-2021 | |
| Medicomp INC | $33.50 | 2025 | Telepatch Cardiac Monitor |
| Averitas Pharma INC. | $25.71 | 2025 | Qutenza |
| Neurocrine Biosciences, INC. | $23.22 | 2025 | |
| Astellas Pharma US INC | $23.20 | 2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.69 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $20.22 | 2021 | |
| Insightec,INC | $19.74 | 2025 | Exablate |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.13 | 2022 | |
| Inspire Medical Systems, INC. | $14.26 | 2025 | Inspire |
| Spinal Elements, INC. | $12.83 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conan Tu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.